EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Challenges and Opportunities for Signal Detection During Public Health Emergencies: An Historical Re-evaluation of the Disproportionality Analysis of the ADR Reporting of Anti-COVID-19 Monoclonal Antibodies in Vigibase

Nicoletta Luxi, Chiara Bellitto, Francesco Ciccimarra, Fabio Scapini, Elena Arzenton, Francesco Maccarrone, Ugo Moretti, Emanuel Raschi, Elisabetta Poluzzi, Daniele Focosi, Jacopo Angelini, Pasquale De Nardo und 4 weitere

Drug Safety · 2026-12 · 49 (12) · 1625-1637

DOI: 10.1007/s40264-026-01705-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Safety, online erschienen am 22.07.2026. Verfasst von Nicoletta Luxi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, COVID-19 Drug Treatment, Antibodies, Monoclonal, Antiviral Agents. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Università degli Studi di Verona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsCOVID-19 Drug TreatmentAntibodies, MonoclonalAntiviral AgentsHumansPharmacovigilanceDatabases, FactualSARS-CoV-2Public Health

Substanzen

Antibodies, MonoclonalAntiviral Agents

Autor:innen und Institutionen

  • Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Piazzale L.A. Scuro 10, 37134, Verona, Italy.
  • Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy.
  • North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
  • Clinical Pharmacology and Toxicology Institute, University Hospital Friuli Centrale ASUFC, 33100, Udine, Italy.
  • Department of Medicine (DMED), University of Udine (UNIUD), Udine, Italy.
  • Infectious Diseases Division, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.

Förderung

  • Università degli Studi di Verona

Zitieren

APA

Luxi, N., Bellitto, C., Ciccimarra, F., Scapini, F., Arzenton, E., Maccarrone, F., Moretti, U., Raschi, E., Poluzzi, E., Focosi, D., Angelini, J., De Nardo, P., Savoldi, A., Tacconelli, E., Trifirò, G., & Tuccori, M. (2026). Challenges and Opportunities for Signal Detection During Public Health Emergencies: An Historical Re-evaluation of the Disproportionality Analysis of the ADR Reporting of Anti-COVID-19 Monoclonal Antibodies in Vigibase. Drug Safety, 49(12), 1625-1637. https://doi.org/10.1007/s40264-026-01705-2

Vancouver

Luxi N, Bellitto C, Ciccimarra F, Scapini F, Arzenton E, Maccarrone F, et al. Challenges and Opportunities for Signal Detection During Public Health Emergencies: An Historical Re-evaluation of the Disproportionality Analysis of the ADR Reporting of Anti-COVID-19 Monoclonal Antibodies in Vigibase. Drug Safety. 2026;49(12):1625-1637. doi:10.1007/s40264-026-01705-2

BibTeX
@article{Luxi2026,
  author = {Luxi, Nicoletta and Bellitto, Chiara and Ciccimarra, Francesco and Scapini, Fabio and Arzenton, Elena and Maccarrone, Francesco and Moretti, Ugo and Raschi, Emanuel and Poluzzi, Elisabetta and Focosi, Daniele and Angelini, Jacopo and De Nardo, Pasquale and Savoldi, Alessia and Tacconelli, Evelina and Trifirò, Gianluca and Tuccori, Marco},
  title = {Challenges and Opportunities for Signal Detection During Public Health Emergencies: An Historical Re-evaluation of the Disproportionality Analysis of the ADR Reporting of Anti-COVID-19 Monoclonal Antibodies in Vigibase},
  journal = {Drug Safety},
  year = {2026},
  volume = {49},
  number = {12},
  pages = {1625--1637},
  doi = {10.1007/s40264-026-01705-2}
}
Kostenlos starten →